| human | Q5 |
| P9956 | IRIS Sapienza author ID | 33314 |
| P496 | ORCID iD | 0000-0002-0262-842X |
| P1053 | ResearcherID | J-8563-2016 |
| P1153 | Scopus author ID | 7003883667 |
| P69 | educated at | Department of Statistical Sciences, Sapienza University of Rome | Q60650497 |
| P108 | employer | George Mason University | Q1411222 |
| Department of Statistical Sciences, Sapienza University of Rome | Q60650497 | ||
| Istituto Superiore di Sanità | Q3803682 | ||
| P735 | given name | Michele | Q18620536 |
| Michele | Q18620536 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q92091998 | A new bioavailable fenretinide formulation with antiproliferative, antimetabolic, and cytotoxic effects on solid tumors |
| Q35836828 | A simple and predictive phenotypic High Content Imaging assay for Plasmodium falciparum mature gametocytes to identify malaria transmission blocking compounds |
| Q46211823 | Activity of the BH3 mimetic ABT-737 on polycythemia vera erythroid precursor cells. |
| Q26780481 | Altered Traffic of Cardiolipin during Apoptosis: Exposure on the Cell Surface as a Trigger for "Antiphospholipid Antibodies" |
| Q40469377 | Antibody Validation by Western Blotting. |
| Q54708119 | Antibody validation by Western blotting. |
| Q38153828 | Approaching the increasing complexity of non-small cell lung cancer taxonomy |
| Q38964120 | C-Met/miR-130b axis as novel mechanism and biomarker for castration resistance state acquisition. |
| Q36340540 | CHK1-targeted therapy to deplete DNA replication-stressed, p53-deficient, hyperdiploid colorectal cancer stem cells |
| Q30729579 | Cancer Stem Cell-Based Models of Colorectal Cancer Reveal Molecular Determinants of Therapy Resistance. |
| Q38548568 | Cancer quasispecies and stem-like adaptive aneuploidy |
| Q46195216 | Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme. |
| Q38823705 | Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1. |
| Q33375296 | Chemotherapy-induced thrombocytopenia derives from the selective death of megakaryocyte progenitors and can be rescued by stem cell factor |
| Q45021445 | Chromosome instability in T-cells cultured in the presence of pancuronium or fentanyl. |
| Q33720256 | Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo |
| Q112719983 | Control of replication stress and mitosis in colorectal cancer stem cells through the interplay of PARP1, MRE11 and RAD51 |
| Q112582937 | Diagnostic and prognostic potential of the proteomic profiling of serum-derived extracellular vesicles in prostate cancer |
| Q47948290 | Drug repurposing for the treatment of glioblastoma multiforme. |
| Q28484249 | EGFR inhibition abrogates leiomyosarcoma cell chemoresistance through inactivation of survival pathways and impairment of CSC potential |
| Q47281255 | Effect of miR-204&211 and RUNX2 control on the fate of human mesenchymal stromal cells. |
| Q28468628 | Exosomes from human colorectal cancer induce a tumor-like behavior in colonic mesenchymal stromal cells |
| Q37690976 | Expression of Iron-Related Proteins Differentiate Non-Cancerous and Cancerous Breast Tumors. |
| Q35069587 | Gene expression analysis of PTEN positive glioblastoma stem cells identifies DUB3 and Wee1 modulation in a cell differentiation model |
| Q39197693 | Gut Mesenchymal Stromal Cells in Immunity |
| Q34925848 | Heat shock proteins and their role in heart injury. |
| Q51585564 | Homologous control of protein signaling networks. |
| Q61784787 | Human neural progenitor cells display limited cytotoxicity and increased oligodendrogenesis during inflammation |
| Q63282794 | Identity and ranking of colonic mesenchymal stromal cells |
| Q35561332 | Increased HMGB1 expression and release by mononuclear cells following surgical/anesthesia trauma |
| Q46872510 | Increased death receptor resistance and FLIPshort expression in polycythemia vera erythroid precursor cells. |
| Q46853183 | Inhibition of DNA methylation sensitizes glioblastoma for tumor necrosis factor-related apoptosis-inducing ligand-mediated destruction |
| Q38731608 | Integrin α7 Is a Functional Marker and Potential Therapeutic Target in Glioblastoma |
| Q81965567 | Lymphocyte apoptosis, caspase activation and inflammatory response in septic shock |
| Q55466441 | Mesenchymal differentiation of glioblastoma stem cells. |
| Q36560256 | Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes With Different Clinical Outcome. |
| Q42984399 | Obesity hormone leptin induces growth and interferes with the cytotoxic effects of 5-fluorouracil in colorectal tumor stem cells. |
| Q64040226 | Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseases |
| Q44581593 | Pancuronium bromide, a non-depolarizing muscle relaxant which promotes apoptosis of blood lymphocytes in vitro. |
| Q42264500 | Pharmacological enhancement of mGlu1 metabotropic glutamate receptors causes a prolonged symptomatic benefit in a mouse model of spinocerebellar ataxia type 1. |
| Q46578185 | Plasma levels of IL-10 and nitric oxide under two different anaesthesia regimens. |
| Q39321299 | Proliferation state and polo-like kinase1 dependence of tumorigenic colon cancer cells. |
| Q35635944 | Propranolol enhances cell cycle-related gene expression in pressure overloaded hearts. |
| Q38702839 | Proteomic analysis of cerebrospinal fluid from children with central nervous system tumors identifies candidate proteins relating to tumor metastatic spread. |
| Q40119016 | Quantum dots for biomedical applications |
| Q36950451 | Reverse-phase protein microarrays: application to biomarker discovery and translational medicine. |
| Q44362013 | Stem cell factor protects erythroid precursor cells from chemotherapeutic agents via up-regulation of BCL-2 family proteins |
| Q52589944 | The Double Face of Exosome-Carried MicroRNAs in Cancer Immunomodulation. |
| Q53750643 | The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response. |
| Q35876285 | Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy. |
| Q36048547 | UCN-01 enhances cytotoxicity of irinotecan in colorectal cancer stem-like cells by impairing DNA damage response. |
| Q36545707 | miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal |
Search more.